Mechanical medical technology · Sophia Antipolis, France

Autonomous Mechanical Infusion Technology

PERFU+3 is a protected mechanical medical technology platform in pre-industrial maturation, designed for emergency, transport and constrained environments where reducing dependence on batteries, electronics or embedded software can be operationally valuable.

100% mechanical No battery No electronics No embedded software
PERFU+3 medical technology with a flexible infusion bag positioned inside the device under a transparent cover
PERFU+3 Illustrative current-design rendering · non-contractual
Mechanical by design Pressure generation and essential operating functions without external electrical power.
100%mechanical operating principle
3French patent applications filed
Controlleddevelopment baseline under configuration management
Pre-industrialmaturation & transfer preparation

Why mechanical autonomy

Reducing technical dependency where conditions are demanding

PERFU+3 explores a deliberately simple approach to pressurised infusion: controlled mechanical compression of a flexible IV bag without a battery, electronic control unit or embedded software.

The operational constraint

Power and electronic dependency can become a limitation

Emergency, transport and degraded environments can impose charging constraints, limited infrastructure, cold exposure, vibration, logistics burden and reduced maintenance capacity.

The PERFU+3 approach

Keep the essential function mechanical

The platform is developed around passive mechanical functions for actuation, guidance, pressure application and limiting, with the objective of a robust and industrially transferable architecture.

Side view of PERFU+3 with transparent cover, infusion bag and mechanical operating lever
Illustrative side rendering showing the mechanical lever and the infusion bag under the transparent cover. Detailed technical definition remains configuration-controlled.

PERFU+3 technology

A passive mechanical platform for controlled bag pressurisation

PERFU+3 is designed to apply controlled mechanical pressure to flexible infusion bags throughout use, without relying on electrical energy or software-driven control.

01

Mechanical pressure application

Stored mechanical energy and guided transmission are used to apply controlled compression to the infusion bag.

02

Passive limiting architecture

Pressure limiting is developed as an independent mechanical function without dependence on electronic sensing or software logic.

03

Human-factor oriented mechanics

Guiding, handling and anti-error features are integrated mechanically to support straightforward preparation and use.

04

Transfer-oriented engineering

The technology is supported by configuration-controlled engineering, risk work and verification planning for future industrial transfer.

Potential environments of use

Designed for demanding medical contexts

The technological relevance of PERFU+3 is strongest where autonomy, simplicity and reduced dependency on electrical infrastructure are desirable.

01

Emergency & pre-hospital

Rapid-deployment contexts where power infrastructure may not be immediately available.

02

Medical transport

Transport situations where compactness and reduced energy dependency can be valuable.

03

Operational health

Potential relevance for tactical and military medical environments requiring robust, battery-free equipment.

04

Disaster response

Degraded or mass-casualty environments in which normal electrical infrastructure cannot be assumed.

05

Remote & austere care

Remote, island, mountain or other constrained environments with demanding logistics.

06

Civil protection

Resilience and continuity-of-care scenarios where equipment independence can support operational readiness.

Defence positioning: military and tactical applications are potential use cases to be evaluated with competent stakeholders. PERFU+3 is not presented as a military-qualified product.

Development status

A protected technology in pre-industrial maturation

PERFU+3 is not a commercial medical device. AXELYUM MEDTECH is continuing technical maturation, verification preparation and industrial-transfer structuring before partner-led industrialisation and regulatory execution.

IP

Protected technology

The technology is supported by three French patent applications. Transfer and rights formalisation are managed separately from the public website.

Engineering

Configuration management

A controlled development baseline is maintained under configuration management as the architecture matures.

Evidence

Structured dossier

Design definition, requirements, risk work and verification documentation are progressively consolidated.

Transfer

Preparation underway

Industrial-transfer documentation and partner-facing materials are being progressively prepared and maintained.

AXELYUM MEDTECH

Develop, protect, mature and transfer mechanical medical technologies

AXELYUM MEDTECH is a French MedTech technology company focused on intellectual property, mechanical medical-device engineering and preparation for industrial transfer.

The company does not position itself as the future series manufacturer. Its model is to create and mature protected technology assets, then engage qualified industrial partners for industrialisation, regulatory execution, manufacturing and market access.

Legal name
AXELYUM MEDTECH SASU
SIREN / SIRET
105 779 011 · 105 779 011 00011
Activity
72.19Z — R&D in physical and natural sciences
Registered office
Les Aqueducs – Bâtiment 3, 535 Route des Lucioles, 06560 Valbonne, France
Founder
Luc Pichotte — Président & Founder
Business model
Technology development · Licensing · Industrial transfer · Co-development

Industrial partnership

Built for qualified industrial dialogue

AXELYUM seeks partners able to assess the technology, contribute to its industrial maturation, execute the regulatory pathway and bring the resulting device to market.

AXELYUM MEDTECH contributes

  • Protected technology and associated know-how
  • Controlled engineering baseline and system architecture
  • Structured engineering, risk and verification documentation
  • Know-how transfer and technical support
  • Flexible licensing or co-development framework

The industrial partner contributes

  • Design-for-manufacture and industrialisation capability
  • Series manufacturing and supplier qualification
  • Regulatory strategy and conformity assessment
  • Clinical / usability work where required
  • Distribution, market access and post-market organisation

Non-confidential documents

Take PERFU+3 with you

Two-page non-confidential overview documents are available for professional and institutional circulation.

ENGLISH · PDF

PERFU+3 Non-Confidential Overview

International overview of the technology, potential applications, maturation pathway and AXELYUM MEDTECH partnering model.

Download English PDF
FRANÇAIS · PDF

PERFU+3 — Présentation non confidentielle

Fiche française de présentation, destinée à la circulation institutionnelle et professionnelle.

Télécharger le PDF français

Qualified enquiries

Discuss PERFU+3 with AXELYUM MEDTECH

For industrial transfer, licensing, co-development, strategic partnership or institutional discussions. Detailed technical information is shared selectively and, where appropriate, under NDA.

Luc Pichotte · Président & Founder AXELYUM MEDTECH SASU · Sophia Antipolis · France luc.pichotte@axelyumhealth.com +33 7 82 17 33 88 · no telephone support service

Use the secure contact form for professional enquiries. The direct email address remains available as a fallback. Please do not send confidential technical information before appropriate confidentiality arrangements are in place.

Open contact form